Furthermore, Myc-regulated Ldha, Pyruvate kinase M2 and Glutaminase have also emerged as promising targets based on experimental models of human cancer [16]–[23], suggesting that targeting various metabolic pathways regulated by Myc may prove beneficial in cancer therapies of patients. Here, LDHA is linked to cancer.